SMS-Livräddaren finalist in Medtech4Health Innovation Award

KI Innovations Aktuellt

SMS Livräddaren is one out of five finalists in Medtech4Health Innovation Award. The mobile application SMS livräddare was developed by a team from Stockholm South General Hospital and has the potential to save lifes by involving so far unexploited resources and facilitate for people to help each other. The potential users in Sweden are the 3 million persons trained within …

Optolexia raises 50 M SEK to enter the US market

KI Innovations Aktuellt

Since the commercial project was initiated in 2013, Optolexia has been extremely successful in developing a tool for dyslexia screening in children at school age. The company has now attracted an investment of 50 million SEK to cross the Atlantic and enter the US market.  Optolexia is one of the companies that has been developed with support from KI Innovations. …

Support for Life Sciences & Health valorization launched!

KI Innovations Aktuellt

You (recently) have finished a health project funded by the European Commission, but are struggling to take your results further? Then the launch of our UTILE project may be of great help to you! Indeed, we just launched UTILE (the EU-health innovation place, a valorization platform for (FP7 Health and H2020 SC1) research results), funded by the European Commission under …

KI leadership visited KI Innovations

KI Innovations Aktuellt

On February 13, Karin Dahlman-Wright, Acting Vice-Chancellor Karolinska Institutet and Per Bengtsson, University Director, visited KI Innovations. The visitors were given the possibility to learn more about the activities at KI Innovations. The visit of the university leadership stemmed from their interest to learn more about the operations at KI Innovations and how the company supports researchers with innovative business ideas. …

Karolinska Institutet research team pioneering the search for a new therapeutic strategy for Huntington disease

KI Innovations Aktuellt

A research team at Karolinska Institutet has developed a novel strategy for Huntington’s disease treatment using novel oligonucleotides directly targeting Huntingtin (HTT) trinucleotide repeat DNA1 sequences, the underlying molecular defect that causes this devastating neurological disease. Partial, but significant, and potentially long-term, HTT knock-down of both mRNA and protein was successfully achieved. Further validation and commercial development of this project …

Apply now for Startup Slam at BIO-Europe Spring!

KI Innovations Aktuellt

Startup Slam is a pitching competition offering innovative entrepreneurs a chance to pitch their company at BIO-Europe Spring. Selected companies will have the opportunity to attend one of the leading partnering events in the global biotechnology industry. Why Pitch at BIO-Europe’s Startup Slam? Receive pitch training from a speaking coach Increase your company’s visibility by pitching to industry executives and …

KI Innovations awarded funding from VINNOVA

KI Innovations Aktuellt

VINNOVA has has decided to fund Karolinska Institutet Innovations AB and SmiLe Incubator in Lund with 2 million SEK for the extension of the project ”Pilot study on life science incubation”.  The first project aimed to strengthen the processes, business and operational models of KI Innovations and SmiLe Incubator as well as identify and propose appropriate indicators to best measure …

Kick-off for new collaborations focused on innovative translational research

KI Innovations Aktuellt

Through its strategic alliance with Johnson & Johnson Innovation, Karolinska Institutet has initiated four separate translational research collaborations with the purpose of addressing important areas of unmet medical need. In May 2015, Karolinska Institutet (KI) entered into a strategic alliance with Johnson & Johnson Innovation to accelerate research emerging from KI that has a transformative potential with respect to healthcare …

Courses in entrepreneurship at Karolinska Institutet

KI Innovations Aktuellt

There are still vacancies in the spring’s courses in entrepreneurship at Karolinska Institutet. The courses of 1.5 credits, can be applied for separately but will give the best output together. The courses are addressed to graduate students and postdocs. They focus on development of opportunities in your research and contains a lot of practical work. Read more in the course …

New call for proposals from the EIT Health – information meeting 16 January

KI Innovations Aktuellt

Andy Browning, European Director of Innovation at EIT Health, will visit Karolinska Institutet to inform about EIT Health’s third announcement of funds for the development of new, innovative products and services in the area ”Healthy Living and Active Ageing”. Day and time: Monday, January 16, 13-15 pm. Venue: Widerströmska Huset, Tomtebodavägen 18A, floor 1, room Wangari. For information about the …